Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-07

FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for trospium chloride from Granules Pharmaceuticals Inc. under ANDA213185. This confirms approval of a generic produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TROSPIUM CHLORIDE

Snippet

SUPPL AP for TROSPIUM CHLORIDE (TROSPIUM CHLORIDE)